Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Vista Gold
VGZ
$328M
| $150K | ﹤0.01% |
+78,533
| New | +$171K |
|
3602
Bally's
BALY
$454M
| $148K | ﹤0.01% |
+10,826
| New | +$138K |
|
3603
KORU Medical Systems
KRMD
$146M
| $148K | ﹤0.01% |
35,336
+9,260
| +36% | +$37.9K |
|
3604
Benitec Biopharma
BNTC
$437M
| $147K | ﹤0.01% |
+10,985
| New | +$130K |
|
3605
Abeona Therapeutics
ABEO
$335M
| $147K | ﹤0.01% |
23,724
+745
| +3% | +$4.09K |
|
3606
SelectQuote
SLQT
$94.5M
| $146K | ﹤0.01% |
173,563
-107,743
| -38% | -$98.1K |
|
|
CPZ
3607
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$255M
| $145K | ﹤0.01% |
11,113
-128
| -1% | -$1.71K |
|
|
BHR
3608
Braemar Hotels & Resorts
BHR
$126M
| $145K | ﹤0.01% |
67,282
-6,217
| -8% | -$14.9K |
|
|
NAKA
3609
Nakamoto Inc
NAKA
$142M
| $145K | ﹤0.01% |
36,774
+21,651
| +143% | +$145K |
|
3610
Children's Place
PLCE
$62M
| $145K | ﹤0.01% |
47,576
-4,749
| -9% | -$16.1K |
|
|
GPMT
3611
Granite Point Mortgage Trust
GPMT
$48.7M
| $144K | ﹤0.01% |
96,054
-5,841
| -6% | -$8.39K |
|
|
YSG
3612
Yatsen Holding
YSG
$256M
| $143K | ﹤0.01% |
45,244
-6,280
| -12% | -$19K |
|
|
CV
3613
CapsoVision Inc
CV
$318M
| $143K | ﹤0.01% |
+18,827
| New | +$127K |
|
3614
Acacia Research
ACTG
$445M
| $142K | ﹤0.01% |
30,527
-46,056
| -60% | -$221K |
|
|
XXI
3615
Twenty One Capital Inc
XXI
$3.3B
| $142K | ﹤0.01% |
28,731
+5,283
| +23% | +$37.1K |
|
3616
Spero Therapeutics
SPRO
$69.3M
| $142K | ﹤0.01% |
64,245
+18,871
| +42% | +$49.4K |
|
|
GRFS
3617
Grifois
GRFS
$5.27B
| $142K | ﹤0.01% |
+20,051
| New | +$158K |
|
3618
Medifast
MED
$136M
| $141K | ﹤0.01% |
13,315
-19,461
| -59% | -$224K |
|
3619
DiaMedica Therapeutics
DMAC
$353M
| $139K | ﹤0.01% |
19,704
-5,095
| -21% | -$31.3K |
|
3620
Soluna Holdings
SLNH
$311M
| $138K | ﹤0.01% |
102,217
-14,747
| -13% | -$21.3K |
|
3621
Viant Technology
DSP
$285M
| $138K | ﹤0.01% |
+10,874
| New | +$123K |
|
3622
Pure Cycle
PCYO
$267M
| $138K | ﹤0.01% |
+12,840
| New | +$140K |
|
|
HUYA
3623
Huya Inc
HUYA
$480M
| $137K | ﹤0.01% |
59,621
-8,280
| -12% | -$23.5K |
|
3624
Eve Holding
EVEX
$784M
| $137K | ﹤0.01% |
54,562
-58,793
| -52% | -$169K |
|
3625
Aegon
AEG
$13.5B
| $137K | ﹤0.01% |
16,211
+1,990
| +14% | +$16.4K |
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.